In a landscape increasingly defined by proactive health management, the United States Thromboprophylactic Drugs Market is set to experience significant expansion, driven by heightened awareness of venous thromboembolism (VTE) risks and innovative anticoagulant advancements. According to a comprehensive new report from Future Market Insights (FMI), the market is forecasted to surge...